Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Slamon

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|July 10, 2003
Herceptin: increasing survival in metastatic breast cancerD Slamon
Seminars in Oncology|April 13, 2001
Rationale for trastuzumab (Herceptin) in adjuvant breast cancer trialsD Slamon, M Pegram
Seminars in Oncology|October 26, 2000
Biological rationale for HER2/neu (c-erbB2) as a target for monoclonal antibody therapyM Pegram, D Slamon
Seminars in Oncology|April 13, 2001
New adjuvant strategies for breast cancer: meeting the challenge of integrating chemotherapy and trastuzumab (Herceptin)J M Nabholtz, D Slamon
Human & Experimental Toxicology|February 24, 2001
Astrocyte phenotype and prevention against oxidative damage in neurotoxicityV W Pentreath, N D Slamon
Alternatives to Laboratory Animals : ATLA|June 5, 2015
A Comparison of the Acute and Chronic Effects of Antidepressants in Cultured C6 and 1321N1 CellsN D Slamon, V W Pentreath
Chemico-Biological Interactions|September 1, 2000
Antioxidant defense against antidepressants in C6 and 1321N1 cellsN D Slamon, V W Pentreath
Oncogene|August 28, 1997
Comparative mutational analysis of DPC4 (Smad4) in prostatic and colorectal carcinomasD MacGrogan, M Pegram, D Slamon, et al.
Cancer Research|July 15, 1990
UCLA colloquium. New insights into breast cancer: the molecular biochemical and cellular biology of breast cancerR B Dickson, M E Lippman, D Slamon
Archives of Toxicology|May 20, 1998
Glutathione modifies the toxicity of triethyltin and trimethyltin in C6 glioma cellsM R Cookson, N D Slamon, V W Pentreath
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|July 10, 2003
Herceptin: increasing survival in metastatic breast cancerD Slamon
Seminars in Oncology|April 13, 2001
Rationale for trastuzumab (Herceptin) in adjuvant breast cancer trialsD Slamon, M Pegram
Seminars in Oncology|October 26, 2000
Biological rationale for HER2/neu (c-erbB2) as a target for monoclonal antibody therapyM Pegram, D Slamon
Seminars in Oncology|April 13, 2001
New adjuvant strategies for breast cancer: meeting the challenge of integrating chemotherapy and trastuzumab (Herceptin)J M Nabholtz, D Slamon
Human & Experimental Toxicology|February 24, 2001
Astrocyte phenotype and prevention against oxidative damage in neurotoxicityV W Pentreath, N D Slamon
Alternatives to Laboratory Animals : ATLA|June 5, 2015
A Comparison of the Acute and Chronic Effects of Antidepressants in Cultured C6 and 1321N1 CellsN D Slamon, V W Pentreath
Chemico-Biological Interactions|September 1, 2000
Antioxidant defense against antidepressants in C6 and 1321N1 cellsN D Slamon, V W Pentreath
Oncogene|August 28, 1997
Comparative mutational analysis of DPC4 (Smad4) in prostatic and colorectal carcinomasD MacGrogan, M Pegram, D Slamon, et al.
Cancer Research|July 15, 1990
UCLA colloquium. New insights into breast cancer: the molecular biochemical and cellular biology of breast cancerR B Dickson, M E Lippman, D Slamon
Archives of Toxicology|May 20, 1998
Glutathione modifies the toxicity of triethyltin and trimethyltin in C6 glioma cellsM R Cookson, N D Slamon, V W Pentreath
Pageof 5